A Study of N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for Lymphoma
Clinical trial NCT05081479 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05081479
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-08
- Primary completion
- 2026-10-21
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.